Insomnia Guide Citations
All citations for the Insomnia Guide, organized by section. Every claim in this guide that draws on external research or professional consensus is sourced here.
- Clinical Guidelines & Major Organizations
- CBT-I: Efficacy & Meta-Analyses
- CBT-I Components
- Assessment & Measurement
- Sleep Environment
- Circadian Rhythm, Light & Melatonin
- Chronotypes & Individual Differences
- Sleep Inertia
- Substances: Caffeine, Alcohol, Exercise
- Distal Vasodilation & Body Temperature
- Food & Nutrition for Sleep
- Sleep Disorders: Apnea & RLS
- Supplements
- Prescription Medications
- Over-the-Counter Aids & Long-Term Risks
- Withdrawal
- Sleep Duration Recommendations
- Aging & Sleep Architecture
Clinical Guidelines & Major Organizations
American Academy of Sleep Medicine (AASM) Guidelines
1. Edinger JD, Arnedt JT, Bertisch SM, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. 2021;17(10):2073-2110.
- DOI: 10.5664/jcsm.8986
- The current AASM guideline on behavioral treatments. This is what established CBT-I as first-line treatment. Pretty much everything in the guide about stimulus control, sleep restriction, cognitive restructuring, relaxation training traces back to here or to the research this synthesizes.
2. Sateia MJ, Buysse DJ, Krystal AD, et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. 2017;13(2):307-349.
- DOI: 10.5664/jcsm.6470
- The medication counterpart to #1. Covers benzos, Z-drugs, orexin antagonists, melatonin receptor agonists, off-label antidepressants, the whole pharmacopeia. Source for the guide's position that meds are secondary to CBT-I.
3. Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. 2017;13(3):479-504.
- DOI: 10.5664/jcsm.6506
- Diagnostic criteria for OSA. Used for the "ruling out" section.
American College of Physicians (ACP) Guideline
4. Qaseem A, Kansagara D, Forciea MA, Pauyo JJ, Casey DE, Dallas RP. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine. 2016;165(2):125-133.
- DOI: 10.7326/M15-2175
- Second major medical organization endorsing CBT-I over medications as first-line. Included because it's not just sleep specialists saying this.
Diagnostic Reference
5. Gottlieb DJ, Punjabi NM. Diagnosis and management of obstructive sleep apnea: a review. JAMA. 2020;324(15):1541-1553.
- DOI: 10.1001/jama.2020.3514
- General overview of OSA for the "what happens at the appointment" section.
CBT-I: Efficacy & Meta-Analyses
6. Trauer JM, Qian MY, Doyle JS, Ritterband LM, Mason MA, Winfield PH, Larsen LH. Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis. Annals of Internal Medicine. 2015;163(3):191-204.
- DOI: 10.7326/M14-2841
- The meta-analysis. The one that showed CBT-I outperforms sleeping pills long-term. Referenced in the intro when I said research shows CBT-I works better than meds in the long run.
7. Mitchell MD, Gehrman M, Perlis ML, Umscheid CA. Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review. BMC Family Practice. 2012;13:40.
- DOI: 10.1186/1471-2296-13-40
- Additional systematic review supporting the same conclusion.
8. Zachariae R, Lyby MS, Ritterband LM, Omvik J, Eidel P, Andersson G. Efficacy of internet-delivered cognitive-behavioral therapy for insomnia--a systematic review and meta-analysis of randomized controlled trials. Sleep Medicine Reviews. 2016;20(1):1-10.
- DOI: 10.1016/j.smrv.2015.05.005
- Supports app-based/digital CBT-I programs like CBT-I Coach and Sleepio. Relevant for the "How Long Does CBT-I Take?" section where I mention those programs.
CBT-I Components
Stimulus Control
9. Bootzin RR. Stimulus control treatment for insomnia. Proceedings of the American Psychological Association. 1972;7:395-396.
- The original paper. All five stimulus control rules in the guide come from this.
10. Jansson-Frojmark M, Nordenstam L. Stimulus control for insomnia: A systematic review and meta-analysis. Journal of Sleep Research. 2024;33(4):e14002.
- DOI: 10.1111/jsr.14002
- Recent meta-analysis validating that it still works.
11. Baillargeon L, Demers M, Martin J. Stimulus-control: nonpharmacologic treatment for insomnia. Canadian Family Physician. 1998;44(1):75-83.
- PMID: 9481465
- Practical guidance on actually implementing it in clinical practice.
12. Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. Journal of Clinical Sleep Medicine. 2008;4(5):487-504.
- PMID: 18853708
- PMCID: PMC2576317
- The AASM clinical practice guideline that explicitly codifies the 15-20 minute rule for getting out of bed. Source for the "if you're awake for more than 20 minutes, get up" instruction throughout the guide.
Sleep Restriction
13. Maurer LF, Schneider J, Miller CB, Espie CA, Kyle SD. The clinical effects of sleep restriction therapy for insomnia: A meta-analysis of randomised controlled trials. Sleep Medicine Reviews. 2021;55:101409.
- DOI: 10.1016/j.smrv.2021.101493
- PMID: 33984745
- Meta-analysis proving sleep restriction works. Cited in that section.
14. Miller CB, Espie CA, Epstein DR, Friedman L, Moritz ZM, McCall LV, Buysse DJ. The evidence base of sleep restriction therapy for treating insomnia disorder. Sleep Medicine Reviews. 2014;18(5):415-424.
- DOI: 10.1016/j.smrv.2014.04.006
- Comprehensive evidence base for the protocols.
15. Falloon K, Elley CR, Fernando A III, Arroll B, Cram F, Gunn LC. Simplified sleep restriction for insomnia in general practice: a randomised controlled trial. British Journal of General Practice. 2015;65(637):e508.
- DOI: 10.3399/bjgp15X687133
- Shows simplified versions can work outside specialist settings.
16. Spielman AJ, Yang CM, Glovinsky P. Sleep Restriction Therapy. In: Behavioral Treatments for Sleep Disorders. Academic Press. 2011.
- Original protocol by the guy who invented sleep restriction therapy. Establishes the 85% threshold for initiating SRT (sleep efficiency below 85%) and the adjustment rules: if efficiency is above 90%, add 15 minutes to time in bed; if below 85% (or 80% in older adults), restrict further; between 85-90%, maintain current window. This is exactly the protocol described in the guide's sleep restriction section.
17. Riedel BW, Lichstein KL. Strategies for evaluating adherence to sleep restriction treatment for insomnia. Behaviour Research and Therapy. 2001;39(2):201-212.
- DOI: 10.1016/S0005-7967(00)00002-4
- PMID: 11153973
- Validates the 90% threshold for expanding time in bed during sleep restriction. Confirms that meeting or exceeding 90% sleep efficiency is the standard trigger for increasing the sleep window by 15-minute increments.
Cognitive Approaches (Paradoxical Intention)
18. Ascher LM, Turner RM. Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy. 1979;17(5):408-411.
- Original study on paradoxical intention.
19. Jansson-Frojmark M, Alfonsson S, Blount J, et al. Paradoxical intention for insomnia: A systematic review and meta-analysis. Journal of Sleep Research. 2022;31(4):e13464.
- DOI: 10.1111/jsr.13464
- Modern confirmation that it still holds up.
Relaxation Training
20. Nicassio PM, Boylan MB, McCabe TG. Progressive relaxation, EMG biofeedback and biofeedback placebo in the treatment of sleep-onset insomnia. British Journal of Medical Psychology. 1982;55(2):159-166.
- Foundational PMR research.
21. Woolfolk RL, McNulty TF. Relaxation treatment for insomnia: a component analysis. Journal of Consulting and Clinical Psychology. 1983;51(3):395-401.
- Component analysis showing which parts actually help.
22. De Niet GJ, Tiemens BG, Kloos MW, Hutschemaekers GJM. Review of systematic reviews about the efficacy of non-pharmacological interventions to improve sleep quality in insomnia. International Journal of Evidence-Based Healthcare. 2009;7(3):215-232.
- DOI: 10.1111/j.1744-1609.2009.00142.x
- Systematic review confirming PMR and other relaxation techniques work.
Breathing Exercises
23. Kurt Aktaş G, Yılmaz Ö, Şahin EM, Kaya B, Akın H, Başaran C, Çelik SS. The Effect of Deep Breathing Exercise and 4-7-8 Breathing Techniques Applied to Patients After Bariatric Surgery on Anxiety and Quality of Life. Obesity Surgery. 2023;33(3):920-929.
- PMID: 36480101
- RCT finding that 4-7-8 breathing significantly reduced state anxiety compared to both deep breathing alone and control groups. Supports the claim that structured breathing activates parasympathetic response and reduces arousal that keeps people awake.
24. Tadavi TA, Mehvish M. A Comparative Study on Box Breathing Technique to Improve the Quality of Sleep in First Year Medical Students. International Journal of Scientific Research. 2023;12(12):1410-1412.
- Comparative study showing box breathing (square breathing) significantly reduced anxiety scores and improved sleep quality vs. control group in a population known for poor sleep. Evidence base for including box breathing alongside 4-7-8 as a viable pre-sleep technique.
25. Frontiers in Sleep Review. The effect of breathing exercises on adults' sleep quality: an intervention that works. Frontiers in Sleep. 2025;4:1603713.
- DOI: 10.3389/frsle.2025.1603713
- Systematic review of breathing exercise interventions (deep breathing, diaphragmatic breathing, mindful breathing, respiratory muscle training) across multiple RCTs from 2000-2024. Consistent improvements in sleep quality across diverse patient populations when practiced regularly for a month or longer.
Body Scan Meditation
26. Black DS, O'Reilly GA, Olmstead R, Breen EC, Irwin MR. Mindfulness Meditation and Improvement in Sleep Quality and Daytime Impairment Among Older Adults With Sleep Disturbances. JAMA Internal Medicine. 2015;175(4):494-501.
- PMID: 25723443
- RCT demonstrating mindfulness meditation including body scan practice significantly improved sleep quality compared to sleep hygiene education alone (effect size d=0.62). Participants showed roughly 18-minute reduction in sleep onset latency. Body scan specifically helps shift attention away from rumination toward bodily sensations, breaking the cycle of lying awake with racing thoughts.
Visualization / Guided Imagery
27. U.S. Department of Veterans Affairs Mental Health. Visualization/Guided Imagery Patient Education Handout. VA VISN 2 Center of Excellence. 2013.
- PDF: VA Guided Imagery Handout
- Evidence-based protocol used in VA/DoD clinical settings. Explains the mechanism: just as thoughts can make your body tense, calming peaceful imagery can produce a relaxed physiological response. Multi-sensory engagement (sight, sound, smell, touch, temperature) makes the technique more absorbing and effective at displacing anxious rumination.
Yoga Nidra
28. Datta K, Tripathi M, Verma M, Masiwal D, Mallick HN. Yoga nidra practice shows improvement in sleep in patients with chronic insomnia: A randomized controlled trial. National Medical Journal of India. 2021;34:143-150.
- DOI: 10.25259/NMJI_63_19
- RCT comparing yoga nidra against CBT-I itself in 41 patients with chronic insomnia. Both groups showed improvements on subjective (sleep diary) and objective (polysomnography) measures. Yoga nidra produced measurable changes in sleep parameters despite being a passive "just lie there and listen" practice.
29. Dutta A, et al. Efficacy of Yoga Nidra in Managing Sleep Disorders: A Systematic Review of Randomized Controlled Trials. Journal of Integrative and Complementary Medicine. 2026;32(3):235-241.
- PMID: 41144325
- Systematic review of 6 RCTs (n=244 total participants) across chronic insomnia, hypertension, acute insomnia, healthcare workers, and athletes. Most studies reported significant improvements in sleep onset latency, total sleep time, and sleep efficiency. Works by reducing respiration rate and producing a state between waking and sleeping.
Relapse Prevention
30. Edinger JD, Carney CE. Cognitive Behavioral Therapy for Insomnia: A Session-by-Session Guide. 2nd ed. Springer. 2019.
- Standard CBT-I treatment manual. The relapse prevention module covers identifying personal high-risk triggers (stress, travel, illness, schedule disruptions), developing specific action plans for each scenario, setting realistic expectations about occasional poor nights being normal even after successful treatment, and knowing when to return to basics vs. seeking professional help again. This is the structure the guide's Phase 4 Consolidation and Maintenance sections follow.
31. Morin CM. Insomnia: Psychological Assessment and Treatment. Guilford Press. 1993.
- Original adaptation of Marlatt and Gordon's relapse prevention model to insomnia. Establishes the framework of anticipating vulnerabilities, planning coping responses, and distinguishing a single bad night from full relapse.
Assessment & Measurement
Insomnia Severity Index (ISI)
32. Bastien CH, Vallieres A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure in insomnia research and treatment. Sleep. 2001;24(Suppl):S63.
- Original validation of the 7-item ISI. Establishes internal consistency (alpha .74-.87), test-retest reliability (.78-.82), concurrent validity with sleep diaries and polysomnography, and optimal cutoff score of 13 or above for clinical insomnia screening (sensitivity .79, specificity .68). This is the questionnaire doctors use to characterize how bad someone's insomnia is, mentioned in the "What Happens at the Appointment" section.
33. Tinc RC, et al. Psychometric Properties of the Insomnia Severity Index (ISI): Diagnostic Performance in Romanian Population. Psychological Assessment. 2026;38(4):319-331.
- DOI: 10.1037/pas0001443
- Recent independent validation confirming the ISI's two-factor structure (sleep difficulty items vs. daytime impact/worry items) holds across populations. Reinforces cutoff of 13 as optimal balance of sensitivity and specificity.
Sleep Diary
34. Carney CE, Buysse DJ, Ancoli-Israel S, Edinger JD, Krystal AD, Lichstein KL, Morin CM. The Consensus Sleep Diary: Standardizing Prospective Sleep Self-Monitoring. Sleep. 2012;35(2):287-302.
- PMID: 22294820
- PMCID: PMC3250369
- The consensus instrument developed by an international panel of sleep experts (including Bootzin, Espie, Morin, Spielman). Standardizes what a sleep diary should record: bedtime, lights-out time, sleep onset latency, number of awakenings, wake-after-sleep onset duration, final awakening time, get-up time, sleep quality rating, and comments. From these you calculate total sleep time, time in bed, and sleep efficiency percentage. This is the format recommended in the Phase 1 Assessment instructions.
Sleep Environment
35. Caddick ZA, Gregory K, Arsintescu LC, Amzica S, Mwafa MG. A review of the environmental parameters necessary for an optimal sleep environment. Building and Environment. 2018;143:106-117.
- DOI: 10.1016/j.buildenv.2018.02.043
- Comprehensive review supporting the temperature, light blocking, sound masking, and other environment recommendations.
36. Xiong J, Lan L, Lian Z, De Dear RJ. Associations of bedroom temperature and ventilation with sleep quality. Science and Technology for the Built Environment. 2020;26:1274-1284.
- DOI: 10.1080/23744731.2020.1756664
- Specific data on bedroom temperature.
Mattress & Pillow Guidance
37. Kirschner JS. Your mattress should last 7-10 years: here's how to tell when you need a replacement. Hospital for Special Surgery / Insider Health Report. 2020.
- HSS Article: Mattress Longevity
- Expert consensus from HSS physiatrist. Standard mattress lifespan is 7-10 years before support and pressure relief degrade enough to affect sleep. Heavier individuals (250+ lbs) may need replacement sooner. Waking up with stiffness or pain the mattress didn't use to cause is the practical signal.
38. Systematic Review. Effect of different pillow designs on promoting sleep comfort, quality, and spinal alignment: A systematic review. Complementary Therapies in Clinical Practice. 2021.
- DOI via ScienceDirect: Pillow Systematic Review
- GRADE-evaluated systematic review of 11 studies (309 participants). Moderate evidence that contoured pillow designs (higher edges for side sleepers, lower middle for back sleepers) promote neutral cervical spine alignment. Optimal unloaded pillow height: 7-11 cm. Latex material and cooling surface associated with better outcomes. Proper alignment reduces neck muscle activation (EMG-validated) and decreases sleep-related neck pain. This supports the guide's statement that pillows should keep your neck aligned with your spine.
Earplugs
39. Healthline Medical Review Board. Sleeping with Earplugs: Benefits, Side Effects, Safety Tips, and Types. Healthline. 2018.
- Link: Earplugs and Sleep
- Medically reviewed summary confirming that soft silicone and wax earplugs provide a more comfortable fit than foam for overnight use because they seal the ear canal entrance rather than expanding inside it. Foam earplugs must be inserted deep into the ear canal to work, which causes pressure, itching, and pain for some people during extended wear. Silicone and wax mold to the shape of the outer ear instead, making them tolerable for people who cannot tolerate foam.
Circadian Rhythm, Light & Melatonin
Light Effects on Melatonin
40. Tahkamo L, Partonen T, Pesonen AK. Systematic review of light exposure impact on human circadian rhythm. Chronobiology International. 2019;36(10):1369-1394.
- DOI: 10.1080/07420528.2018.1527773
- How light suppresses melatonin. Basis for the screens/blue light discussion.
41. Oh JH, Yoo HK, Park HK, Do YR. Analysis of circadian properties and healthy levels of blue light from smartphones at night. Scientific Reports. 2015;5:11325.
- DOI: 10.1038/srep11325
- PMID: 26085126
- PMCID: PMC4471664
- Smartphone-specific data on blue light effects.
Red/Amber Night Lights
42. PMC Review. Understanding Red Light's Impact on Melatonin Secretion Regulation. PMC. 2015.
- PMCID: PMC4311741
- Reviews photoreceptor sensitivity data. Melanopsin (the circadian photoreceptor) is least sensitive to long-wavelength red light (620-700nm) compared to blue light (446-477nm). Red and amber night lights at low illuminance levels produce minimal melatonin suppression and minimal circadian phase shifting. This is why the guide recommends red/amber night lights over white or blue ones for bathroom trips and necessary nighttime lighting.
Morning Light Exposure
43. Chambe J, Reynaud E, Maruani J, et al. Light therapy in insomnia disorder: A systematic review and meta-analysis. Journal of Sleep Research. 2023;32(2):e13895.
- DOI: 10.1111/jsr.13895
- Meta-analysis confirming bright light therapy (especially morning exposure) improves sleep onset, sleep maintenance, and circadian timing across all insomnia subtypes. This is the evidence base for getting morning light to anchor your rhythm.
44. Lack L, Wright H, Paynter D. The treatment of sleep onset insomnia with bright morning light. Sleep and Biological Rhythms. 2007;1(1):15-23.
- Direct RCT showing morning bright light alone improves sleep onset latency in people with sleep-onset insomnia without any other intervention. Clean, targeted evidence.
Melatonin: Dosing, Efficacy, Safety
45. Zhdanova IV, Wurtman RJ, Regan MM, Lieberman HR, Fertner JW. Melatonin treatment for age-related insomnia. Journal of Clinical Endocrinology & Metabolism. 2001;86(10):4727-4733.
- DOI: 10.1210/jcem.86.10.7901
- PMID: 11600532
- The study that established physiological doses (0.3-0.5 mg) work. Why I told people most commercial pills are overdosed.
46. Auld F, Maschauer EL, Morrison I, Skene DJ, Blagrove J. Evidence for the efficacy of melatonin in treating primary adult sleep disorders. Sleep Medicine Reviews. 2017;34:10-24.
- DOI: 10.1016/j.smrv.2016.06.005
- PMID: 28648359
- Shows melatonin works better for circadian issues than general insomnia. Effect sizes are modest (about 5-10 minutes faster sleep onset).
47. Choi KY, Lee YJ, Park S, Je NK, Suh HS. Efficacy of melatonin for chronic insomnia: Systematic reviews and meta-analyses. Sleep Medicine Reviews. 2022;59:101561.
- DOI: 10.1016/j.smrv.2022.101692
- PMID: 36179487
- Most recent comprehensive meta-analysis.
48. Menczel Schrire Z, Phillips CL, de Zwanik RA, Lipinski SE, Chesnokova GN, Bloch MR. Safety of higher doses of melatonin in adults: a systematic review and meta-analysis. Journal of Pineal Research. 2022;73(1):e12782.
- DOI: 10.1111/jpi.12782
- Safety data supporting the warning about high-dose pills being unnecessary.
Melatonin Withdrawal & Endogenous Production
49. Wade AG, Ford I, Crawford G, et al. Prolonged-release melatonin for insomnia: An open-label study. Sleep Medicine. 2011;12(4):393-400.
- PMCID: PMC3150476
- Critical long-term safety data. Patients took prolonged-release melatonin nightly for 12 months then stopped. Discontinuation was NOT associated with adverse events, withdrawal symptoms, OR suppression of endogenous melatonin production. Cited by 111+ subsequent papers. This directly addresses the common worry that taking melatonin supplements will cause your body to stop making its own. The evidence says that concern is unfounded for physiologic-dose extended-release formulations used up to a year.
50. Givler D, Givler A, Luther PM, Wenger DM, Ahmadzadeh S, Shekoohi S, Edinoff AN, Dorius BK, Kaye AM, Kaye AD. Chronic Administration of Melatonin: Physiological and Clinical Considerations. Biomolecules. 2023;15(1):31.
- DOI: 10.3390/biom15010031
- Narrative review covering evolving concerns about chronic melatonin use. Confirms that most studies do not find clinically significant suppression of endogenous production even with sustained use. Notes that supplement quality control remains inconsistent (actual content varies from label claims).
Chronotypes & Individual Differences
51. Roepke SE, Duffy JF. Differential impact of chronotype on weekday and weekend sleep timing and duration. Nature and Science of Sleep. 2010;2:57-64.
- DOI: 10.2147/NSS.S12572
- Connects chronotype (morning vs evening preference) directly to social jet lag. Evening types suffer more from being forced into early schedules. Some people aren't staying up late by choice; they're fighting their biology.
52. Adan A, Natale V. Gender differences in morningness-eveningness preference. Chronobiology International. 2002;19(4):709-720.
- PMID: 12182498
- Major review (776 citations) covering individual differences in circadian preferences. Establishes that chronotypes are real, measurable, and have genuine impacts on sleep timing and quality.
Sleep Inertia
53. Hilditch CJ, McHill AW. Sleep inertia: current insights. Nature and Science of Sleep. 2019;11:13-21.
- DOI: 10.2147/nss.s188911
- Comprehensive modern review. Sleep inertia is a real physiological phenomenon, not just "being groggy." Lasts 15-60 minutes typically, worse when awakened from deep sleep, impairs performance even though you feel awake. Distinct from ordinary sleepiness.
54. Trotti LM. Waking up is the hardest thing I do all day: sleep inertia and sleep drunkenness. Sleep Medicine Reviews. 2017;35:102-114.
- PMCID: PMC5337178
- Covers "sleep drunkenness" (severe sleep inertia) as a clinically significant problem. Discusses what makes it worse: sleep deprivation, awakening from slow-wave sleep, circadian misalignment. 282 citations.
Substances: Caffeine, Alcohol, Exercise
Caffeine Mechanism & Pharmacokinetics
55. Fredholm BB, Battig K, Holmen J, Persson MA, Stromberg P, Astrom K, Josephson M. Actions of caffeine in the brain with special reference to adenosine receptors. Pharmacological Reviews. 1999;51(1):83-133.
- PMID: 10049999
- Mechanism of action (adenosine receptor antagonism) and half-life data. Source for the caffeine section's explanation of how it works and why timing matters.
56. NCBI Bookshelf / National Library of Medicine. Pharmacology of Caffeine. In: Principles of Addiction Medicine. 2009.
- Link: NCBI NBK223808
- Official pharmacokinetic reference. Mean plasma half-life of caffeine in healthy adults is approximately 5 hours, but elimination half-life ranges from 1.5 to 9.5 hours depending on individual variation. Factors affecting metabolism include genetic polymorphisms (CYP1A2 enzyme activity differences), pregnancy, oral contraceptive use, smoking status, obesity, altitude, and liver function. This is the source for the guide's statement that "individual metabolism varies" and "some people clear it faster, some slower."
57. Porkka-Heiskanen T, Alanko L, Stenberg D. Adenosine, energy metabolism and sleep homeostasis. Sleep Medicine Reviews. 2011;15(2):123-135.
- DOI: 10.1016/j.smrv.2010.06.005
- PMID: 20970361
- Explains adenosine buildup and sleep pressure. What caffeine is masking.
58. Holst SC, Landolt HP. Sleep homeostasis, metabolism, and adenosine. Current Sleep Medicine Reports. 2015;1(1):27-37.
- DOI: 10.1007/s40675-014-0007-3
- Confirms the ~5 hour half-life used for the caffeine cutoff calculations.
Alcohol Effects on Sleep Architecture
59. Thakkar MM, Sharma R, Sahota P. Alcohol disrupts sleep homeostasis. Alcohol. 2015;49(4):299-310.
- DOI: 10.1016/j.alcohol.2015.03.009
- REM suppression, fragmentation, rebound effect, diuretic effect, airway relaxation. Heavily cited in the alcohol section.
60. Koob GF, Colrain IM. Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework. Neuropsychopharmacology. 2020;45(1):141-165.
- DOI: 10.1038/s41386-019-0514-5
- Rebound insomnia and long-term architecture disruption.
61. Chan JK, Trinder JE, Andrewes HE, Colrain IM, Fein D. The acute effects of alcohol on sleep architecture in late adolescence. Alcoholism: Clinical and Experimental Research. 2013;37(6):1520-1533.
- PMCID: PMC3987855
- Specific REM suppression data.
Exercise Timing & Physiology
62. Kim N, Ka S, Park J. Effects of exercise timing and intensity on physiological circadian rhythm and sleep quality: a systematic review. Physical Activity and Nutrition. 2023;27(2):29-42.
- PMCID: PMC10636512
- Data supporting the exercise timing recommendations.
63. Shen B, Ma C, Wu G, Liu H, Chen L. Effects of exercise on circadian rhythms in humans. Frontiers in Pharmacology. 2023;14:1282357.
- DOI: 10.3389/fphar.2023.1282357
- Why vigorous exercise too close to bedtime interferes with sleep onset (temp, cortisol, heart rate).
Distal Vasodilation & Body Temperature
64. Krauchi K, Cajochen C, Werth E, Wirz-Justice A. Functional link between distal vasodilation and sleep-onset latency? American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2000;278(3):R741-R748.
- DOI: 10.1152/ajpregu.2000.278.3.R741
- PMID: 10712296
- THE foundational paper on this mechanism (479 citations). Dilation of blood vessels in hands and feet precedes sleep onset by about 80 minutes. Warm feet aren't cozy; they're part of the physiological cascade that initiates sleep. This is why warm baths/showers help.
65. Haghayegh S, Khademi A, Smolensky MH, Boland-Carter J, Endler PC, Labrecque JA, Chamberlain SS, Jarjoura D, Vernet R, Dawson D, Di Monte-Gonzalez J. Before-bedtime passive body heating by warm shower or bath to improve sleep: A systematic review and meta-analysis. Sleep Medicine Reviews. 2019;46:28-36.
- DOI: 10.1016/j.smrv.2019.04.008
- Meta-analysis of 17 qualifying studies (from 5322 candidate articles). Water temperature of 40-42.5C (104-108.5F) for 10+ minutes, scheduled 1-2 hours before bedtime, reduced sleep onset latency by approximately 36% and improved subjective sleep quality. The mechanism: peripheral vasodilation increases blood flow to palms and soles, which augments the distal-to-proximal skin temperature gradient and enhances core body heat dissipation. That heat loss triggers the natural core temperature drop that signals sleep onset. This is the source for the "warm shower or bath an hour or two before bed" recommendation.
66. Zhao J, Wang F, Ou D, Zhou B, Li Y, Wang H, et al. Thermoregulatory analysis of warm footbaths before bedtime: Implications for enhancing sleep quality. Building and Environment. 2023;246:110819.
- DOI: 10.1016/j.buildenv.2023.110819
- Recent practical study testing different water temperatures and durations for warm footbaths. Gives actionable specifics if someone wants to try using foot warmth to fall asleep faster.
Food & Nutrition for Sleep
67. Howatson G, Bell PG, Tallent J, Middleton B, McHugh MP, Ellis J. Effect of tart cherry juice (Prunus cerasus) on melatonin levels and enhanced sleep quality. European Journal of Nutrition. 2012;51(8):909-916.
- PMID: 22038497
- DOI: 10.1007/s00394-011-0263-7
- Randomized, double-blind, placebo-controlled crossover trial (n=20 healthy adults). Tart cherry juice concentrate consumed for 7 days significantly elevated total urinary melatonin content (P<0.05) and produced significant increases in time in bed, total sleep time, and sleep efficiency on actigraphy. Montmorency tart cherries contain measurable melatonin. Not magic, but real.
68. Lin HH, Tsai PS, Fang SC, Liu JF. Effect of kiwifruit consumption on sleep quality in adults with sleep problems. Asia Pacific Journal of Clinical Nutrition. 2011;20(2):169-174.
- PMID: 21669584
- Free-living self-controlled diet design (n=24 adults, ages 20-55). Two kiwifruits consumed 1 hour before bedtime nightly for 4 weeks. Results: subjective sleep quality score decreased 42.4%, waking time after sleep onset decreased 28.9%, sleep onset latency decreased 35.4%, total sleep time increased 13.4%, and sleep efficiency increased 5.41%. Kiwi contains serotonin, folate, and antioxidants that may contribute to the effect.
69. Doherty R, Madigan S, Nevill A, Warrington G, Ellis JG. The Impact of Kiwifruit Consumption on the Sleep and Recovery of Elite Athletes. Nutrients. 2023;15(10):2274.
- DOI: 10.3390/nu15102274
- More recent study in elite athletes confirming positive effects of 2 green kiwifruit daily for 4 weeks on sleep parameters and recovery markers. Replicates Lin et al.'s findings in a different population.
Sleep Disorders: Apnea & RLS
Obstructive Sleep Apnea
70. Laratta CR, Ayas NT, Povitz M, Pendharkar SR. Diagnosis and treatment of obstructive sleep apnea in adults. Canadian Medical Association Journal. 2019;197:E1481-E1488.
- PMCID: PMC5714915
- OSA overview for the ruling-out section.
Restless Leg Syndrome / Willis-Ekbom Disease
71. Allen RP. Restless leg syndrome/Willis-Ekbom disease pathophysiology. Sleep Medicine Clinics. 2015;10(3):207-214.
- PMCID: PMC4559751
- PMID: 26329430
- Pathophysiology and diagnostic criteria.
72. Garcia-Borreguero D, Kohnen R, Silber MH, Yeh JLZ. The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group (IRLSSG). Sleep Medicine. 2013;14(7):675-684.
- DOI: 10.1016/j.sleep.2013.05.016
- Treatment guidelines. Referenced when I said RLS is worth getting checked out.
Supplements
Magnesium
73. Abbasi B, Kimiagar M, Sadeghniiat H, Hafezi Y, Haghayegh A, Hatami M, Khoshkholaghi E. The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial. Journal of Research in Medical Sciences. 2012;17(1161):1161-1169.
- PMCID: PMC3703169
- RCT showing magnesium improves sleep in elderly populations.
74. Mah J, Pitre T. Oral magnesium supplementation for insomnia in older adults: a systematic review & meta-analysis. BMC Complementary Medicine and Therapies. 2021;21(1):164.
- DOI: 10.1186/s12906-021-03297-z
- Meta-analysis confirming modest benefits for insomnia specifically.
75. Chan V, Lo K. Efficacy of dietary supplements on improving sleep quality: a systematic review and meta-analysis. Postgraduate Medical Journal. 2022;98:105806.
- DOI: 10.1136/postgradmedj-2020-139319
- Includes magnesium among supplements with actual evidence.
L-Theanine
76. Mátyás RO, Szikora Z, Bodó D, Szabó BV, Csupor É, Csupor D, Tóth B. Promising, but Not Completely Conclusive: The Effect of L-Theanine on Cognitive Performance Based on Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Clinical Trials. Journal of Clinical Medicine. 2025;14(21):7710.
- DOI: 10.3390/jcm14217710
- Comprehensive meta-analysis of RCTs evaluating L-theanine (typically 100-200mg doses, the amount found in green tea) on cognitive function, relaxation, and anxiety. Found in tea leaves (Camellia sinensis). Promotes relaxation without sedation. Generally well-tolerated. Evidence is promising but not yet conclusive for sleep-specific outcomes.
Glycine
77. Yamadera W, Inoue S, Nakamura S, Kawamata R, Harada T. Glycine ingestion improves subjective sleep quality in human volunteers. Neuropsychopharmacology. 2007;32(5):1081-1087.
- DOI: 10.1111/j.1479-8425.2007.00262.x
- Human volunteer study. 3 grams of glycine ingested before bedtime significantly improved subjective sleep quality, reduced daytime sleepiness, and improved memory consolidation performance the next morning. Glycine is the simplest amino acid and functions as an inhibitory neurotransmitter. Cheap, safe, no serious side effects at this dose.
78. Bannai M, Kawai N, Ono J, Yahata N, Tokunaga Y, Tsubone H, Suwazono Y. New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep. Biological Pharmaceutical Bulletin. 2012;35(2):207-212.
- PMID: 22293292
- Follow-up study elaborating mechanisms: glycine lowers core body temperature through cutaneous vasodilation (similar to warm bath effect), modulates NMDA receptors in the suprachiasmatic nucleus (circadian pacemaker), and may increase serotonin turnover. 3g before bed remains the studied dose.
Chamomile
79. Adib-Hajbaghery M, Mousavi SM, Akbari H, Haghbin F, Rahgozar M. The effects of chamomile extract on sleep quality among elderly people: A clinical trial. Complementary Therapies in Medicine. 2017;35:109-114.
- PMID: 29154054
- DOI: 10.1016/j.ctim.2017.09.010
- Single-blind RCT in 60 elderly participants. 200mg chamomile extract twice daily for 28 days showed improvement in some sleep quality components but not others. Safe and well-tolerated.
80. Cairo V, Griffith RA, Nielsen CK, Rosenthal NE, Camfield DA, Riggs GS, Truman KA, Moss HB. Preliminary examination of the efficacy and safety of a standardized chamomile extract for chronic primary insomnia: A randomized placebo-controlled pilot study. BMC Complementary and Alternative Medicine. 2011;11:78.
- Link: Chamomile Pilot Study
- Double-blind RCT, n=34 patients with chronic primary insomnia (DSM-IV criteria), 270mg chamomile twice daily or placebo for 28 days. No significant differences between groups in total sleep time, sleep efficiency, sleep latency, wake after sleep onset, or number of awakenings. Modest non-significant trends favoring chamomile on some measures. Effect sizes small to moderate. Conclusion: chamomile shows mixed benefits, is safe, but is not a reliable standalone treatment for chronic insomnia. This matches the guide's characterization: "mild calming effect, mostly harmless."
Other Supplements
81. Bent S, Padula A, Moore D, et al. Valerian for sleep: a systematic review and meta-analysis. American Journal of Medicine. 2006;119(12):1005-1012.
- DOI: 10.1016/j.amjmed.2006.02.026
- Valerian. Mixed results, which is why I said the evidence isn't strong.
82. Cheah KL, Norhayati MN, Husniati Yaacob L, et al. Effect of ashwagandha on sleep quality: a systematic review. Complementary Therapies in Medicine. 2021;60:102734.
- DOI: 10.1016/j.ctim.2021.102734
- Ashwagandha. Rigorous evidence is sparse. Enthusiasm exceeds data.
83. Jamnekar PP, et al. Ashwagandha as an Adaptogenic Herb: A Comprehensive Review of Immunological and Neurological Effects. Cureus. 2025;17(11):e96183.
- DOI: 10.7759/cureus.96183
- Ashwagandha. Not a sleep aid by any reasonable definition.
5-HTP Interaction Warning
84. Gillman PK. The serotonin syndrome. Australian and New Zealand Journal of Psychiatry. 1999;33(4):549-555.
- PMID: 10221364
- Safety warning. 5-HTP can interact dangerously with SSRIs, SNRIs, tramadol, etc. Included so nobody hurts themselves.
Prescription Medications
Benzodiazepines
85. Petursson H. The benzodiazepine withdrawal syndrome. Addiction. 1994;89(11):1615-1624.
- DOI: 10.1111/j.1360-0443.1994.tb03743.x
- Withdrawal severity, timeline (onset 1-3 days, peaks days 3-7), symptoms including seizures. This is why the withdrawal section says don't do this alone.
86. Chouinard G. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. Journal of Clinical Psychiatry. 2004;65(Suppl 5):7-12.
- PMID: 15078112
- Importance of slow tapering.
87. Kales A, Soldatos CR, Bixler EO, Kales JD. Rebound insomnia: a potential hazard following withdrawal of certain benzodiazepines. JAMA. 1979;241(16):1692-1695.
- PMID: 430730
- DOI: 10.1001/jama.241.16.1692
- Classic paper defining rebound insomnia.
88. Gillin JC, Spinweber CL, Johnson LC. Rebound insomnia: a critical review. ADA205546. 1987.
- DTIC: ADA205546
- Additional analysis.
Z-Drugs (Non-Benzodiazepine Hypnotics)
89. Edinoff AN, Wu N, Ghaffar YT, et al. Zolpidem: efficacy and side effects for insomnia. Health Psychology Research. 2021;9(1):24927.
- PMCID: PMC8567759
- Zolpidem review covering both efficacy and complex sleep behaviors.
90. Mittal N, Mittal R, Gupta MC. Zolpidem for insomnia: a double-edged sword. A systematic literature review on Zolpidem-induced complex sleep behaviors. Indian Journal of Psychological Medicine. 2021;32(3):262-270.
- DOI: 10.1177/0253717621992372
- Documents the sleepwalking, sleep-eating, sleep-driving reports.
91. Harbourt K, Nevo ON, Zhang R, Chan V, et al. Association of eszopiclone, zaleplon, or zolpidem with complex sleep behaviors resulting in serious injuries, including death. Drug Safety. 2023;53(6):1041-1054.
- PMID: 32323442
- FDA adverse event data confirming serious risks.
92. Lader M. Rebound insomnia and newer hypnotics. Psychopharmacology. 1992;108(3):248-255.
- DOI: 10.1007/BF02245108
- Z-drug rebound potential compared to benzos.
Orexin Receptor Antagonists (Newer Class)
93. Bennett T, Bray D, Neville MW. Suvorexant, a dual orexin receptor antagonist, for the management of insomnia. Pharmacy & Therapeutics. 2014;39(4):264-278.
- PMCID: PMC3989084
- How orexin antagonists work. Turning off the stay awake signal.
94. Herring WJ, Snyder E, Budd K, Hutzelmann M, Yao B, Bhatt NK, Lankford GD, et al. Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant. Neurology. 2012;79(11):1297-1304.
- PMCID: PMC3574890
- Landmark RCT.
95. Coleman PJ, Gotter AL, Herring WJ. The discovery of suvorexant, the first orexin receptor drug for insomnia. Annual Review of Pharmacology and Toxicology. 2017;57:513-533.
- DOI: 10.1146/annurev-pharmtox-010716-104837
- Background on the drug class.
96. Norman JL, Anderson SL. Novel class of medications, orexin receptor antagonists, in the treatment of insomnia--critical appraisal of suvorexant. Nature and Science of Sleep. 2016;6:80-91.
- PMCID: PMC4948724
- Critical appraisal addressing abuse potential, next-day effects, limited long-term data.
Melatonin Receptor Agonists
97. Ramelteon (Rozerem) FDA Label Information / Prescribing Information. Takeda Pharmaceutical Co., Ltd. / Eisai Inc.
- DailyMed: b336438f-7951-d3b7-e053-2995a90a4d69
- Mechanism, safety profile (no abuse potential, no rebound), limitations (onset only).
Sedating Antidepressants (Off-Label Use)
98. Mendelson WB. A review of the evidence for the efficacy and safety of trazodone in insomnia. Journal of Clinical Psychiatry. 2005;66(4):469-476.
- PMID: 15816789
- Trazodone review. Side effects, priapism risk included.
99. Jaffer KY, Chang T, Vanle B, Dang J, Yoon SY, Han OS, Chung IS, Lee Y, Han JY, Jung YW, Kim BS, Woo YI, Lee JS. Trazodone for insomnia: a systematic review. Innovative Clinical Neuroscience. 2017;14(7-8):24.
- PMCID: PMC5842888
- Systematic review confirming efficacy for sleep maintenance insomnia.
100. Yi X, Ni S, Ghadami MR, Meng H, Chen L, Kuang S. Trazodone for the treatment of insomnia: a meta-analysis of randomized placebo-controlled trials. Sleep Medicine. 2018;42(7):1093-1100.
- PMID: 29680424
- Meta-analysis quantifying effect size.
Gabapentin/Pregabalin
101. Hong JSW, Atkinson LZ, Al-Juffali N, Awad A, Geddes JR, Tunbridge EM, Harrison PJ, Cipriani A. Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale. British Journal of Psychiatry. 2021;218(6):389-398.
- PMID: 34819636
- DOI: 10.1192/bjp.2020.176
- Systematic review and meta-analysis from Oxford University Psychiatry Department. Analyzed 55 double-blind RCTs and 15 open-label studies across bipolar disorder, anxiety, and insomnia indications. For insomnia specifically: results were inconclusive. Minimal evidence of efficacy despite widespread off-label prescribing. Moderate evidence for anxiety states, but the insomnia data simply isn't there. This replaces the earlier off-label overview citation with the definitive systematic review.
Over-the-Counter Aids & Long-Term Risks
102. Gray SL, Anderson ML, Dublin S, Lykes DL, Beckett LA, Arai SM. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Internal Medicine. 2015;175(3):401-409.
- PMCID: PMC4358759
- The dementia risk study. This is why the OTC section warns about long-term diphenhydramine use.
103. Tannenbaum C, Paquette A, Hilmer S, Holroyd-Leduc J, Carnahan R. A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs. Drugs & Aging. 2012;29(8):639-658.
- DOI: 10.1007/BF03262280
- Anticholinergic cognitive burden mechanisms.
104. Basu R, Dodge H, Stoehr GP, Ganguli M. Sedative-hypnotic use of diphenhydramine in a rural, older adult, community-based cohort: effects on cognition. American Journal of Geriatric Psychiatry. 2003;11(2):205-213.
- PMCID: PMC1494308
- Direct study of diphenhydramine cognitive effects in older adults.
Withdrawal
Benzodiazepine Withdrawal Severity
105. Chouinard G. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. Journal of Clinical Psychiatry. 2004;65(Suppl 5):7-12.
- PMID: 15078112
- Importance of slow tapering.
Z-Drug Withdrawal
106. Hajak G, Clarenbach P, Fischer J, Holter C, Ising M. Rebound insomnia after hypnotic withdrawal in insomniac outpatients. European Archives of Psychiatry and Clinical Neurosciences. 1998;248(3):148-156.
- DOI: 10.1007/s004060050032
- Milder than benzos but still requires tapering. Seizure risk exists but is rarer.
Sleep Duration Recommendations
107. Hirshkowitz M, Whiton K, Albert SM, Alessi C, Bruni O, Eit CA, Watson NF, Morales CMM, Patel SR, Goode CT. National Sleep Foundation's sleep time duration recommendations: methodology and results summary. Sleep Health. 2015;1(1):40-43.
- PMCID: PMC4507722
- Establishes the 7-9 hour range with individual variation. Debunks the everyone-needs-exactly-8-hours myth.
108. Watson NF, Badr SM, Belenky G, Dinges DF, Walsh AW, Colten ER, Kang JE, Wright Jr KP. Recommended amount of sleep for a healthy adult: a joint consensus statement of the American Academy of Sleep Medicine and Sleep Research Society. Journal of Clinical Sleep Medicine. 2015;11(8):943-947.
- DOI: 10.5664/jcsm.4758
- Joint AASM/SRS consensus reinforcing 7+ hours.
Aging & Sleep Architecture
109. Koffel E, Ancoli-Israel Z, Zee PC, Dzierzewski JM. Sleep health and aging: Recommendations for promoting healthy sleep among older adults: A National Sleep Foundation report. Sleep Health. 2023;9(3):223-239.
- DOI: 10.1016/j.sleh.2023.01.001
- Addresses the "older people need less sleep" myth. Need stays similar, architecture changes (more fragmented, less deep sleep, earlier schedule).
Mental Health Comorbidity
110. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA. 1989;262(11):1479-1484.
- DOI: 10.1001/jama.1989.03430110069030
- PMID: 2769898
- Landmark epidemiologic study establishing that 40% of those with insomnia had a comorbid psychiatric disorder, compared to 16% of those without insomnia. The relationship is bidirectional.
111. Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U, Lombardo C, Riemann D. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. Journal of Affective Disorders. 2011;135(1-3):10-19.
- DOI: 10.1016/j.jad.2011.01.011
- PMID: 21300408
- Meta-analysis of 21 longitudinal studies. Non-depressed people with insomnia have a twofold risk of developing depression compared to people without sleep difficulties. Establishes insomnia as a predictor, not just a symptom.
112. Krakow B, Hollifield M, Johnston L, Koss M, Schrader R, Warner TD, Tandberg D, Lauriello J, McBride L, Cutchen L, Cheng D, Emmons S, Germain A, Melendrez D, Sandoval D, Prince H. Imagery rehearsal therapy for chronic nightmares in sexual assault survivors with posttraumatic stress disorder: a randomized controlled trial. JAMA. 2001;286(5):537-545.
- DOI: 10.1001/jama.286.5.537
- PMID: 11476655
- Landmark RCT establishing imagery rehearsal therapy (IRT) as effective for trauma-related nightmares. Participants who received IRT had significantly fewer nightmares and improved sleep quality compared to controls.
113. Casement MD, Swanson LM. A meta-analysis of imagery rehearsal for post-trauma nightmares: effects on nightmare frequency, sleep quality, and posttraumatic stress. Sleep Medicine Reviews. 2012;16(6):566-574.
- DOI: 10.1016/j.smrv.2012.02.002
- PMCID: PMC3409327
- Meta-analysis confirming IRT reduces nightmare frequency and improves sleep quality in PTSD populations.
Sex and Gender Differences
114. Zhang B, Wing YK. Sex differences in insomnia: a meta-analysis. Sleep. 2006;29(1):85-93.
- DOI: 10.1093/sleep/29.1.85
- PMID: 16453985
- Meta-analysis of 29 studies (n=1,265,015). Women have a risk ratio of 1.41 for insomnia compared to men. The female predominance emerges at puberty and persists across the lifespan. Not fully explained by reporting bias.
115. Suh S, Cho N, Zhang J. Sex Differences in Insomnia: from Epidemiology and Etiology to Intervention. Current Psychiatry Reports. 2018;20(9):69.
- DOI: 10.1007/s11920-018-0940-9
- PMID: 30094679
- Comprehensive review covering hormonal contributors (menstrual cycle, pregnancy, menopause) and sex-specific treatment considerations.
116. Baker FC, Driver HS. Circadian rhythms, sleep, and the menstrual cycle. Sleep Medicine. 2007;8(6):613-622.
- DOI: 10.1016/j.sleep.2006.09.011
- PMID: 17383933
- Review establishing that subjective sleep quality decreases and sleep disruption increases during the luteal phase, particularly in women with premenstrual symptoms.
117. Kravitz HM, Ganz PA, Bromberger J, Powell LH, Sutton-Tyrrell K, Meyer PM. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause. 2003;10(1):19-28.
- PMID: 12544673
- DOI: 10.1097/00042192-200301000-00005
- Large community survey (n=12,603) finding 38% of perimenopausal and postmenopausal women report sleep difficulty, with hot flashes as a primary contributor.
118. Joffe H, Massler A, Sharkey KM. Evaluation and management of sleep disturbance during the menopause transition. Seminars in Reproductive Medicine. 2010;28(5):404-421.
- DOI: 10.1055/s-0030-1262900
- PMCID: PMC2966578
- Review covering mechanisms and treatment approaches for menopausal sleep disruption.
Sleep Paralysis and Parasomnias
119. Sharpless BA, Barber JP. Lifetime prevalence rates of sleep paralysis: a systematic review. Sleep Medicine Reviews. 2011;15(5):311-315.
- DOI: 10.1016/j.smrv.2011.01.007
- PMCID: PMC3156892
- Systematic review finding approximately 7.6% lifetime prevalence in the general population, higher in students (28%) and psychiatric populations (32%). Confirms association with sleep deprivation and irregular sleep schedules.
120. Denis D, French CC, Gregory AM. A systematic review of variables associated with sleep paralysis. Sleep Medicine Reviews. 2018;38:141-157.
- DOI: 10.1016/j.smrv.2017.05.005
- PMID: 28648782
- Comprehensive review confirming sleep paralysis is generally benign and strongly associated with sleep disruption, shift work, and insomnia.
121. Schenck CH, Mahowald MW. REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep. 2002;25(2):120-138.
- DOI: 10.1093/sleep/25.2.120
- PMID: 11902423
- Definitive review establishing RBD as distinct from other parasomnias and noting its association with synucleinopathies (Parkinson's disease, Lewy body dementia).
122. Postuma RB, Iranzo A, Hu M, Högl B, Boeve BF, Manni R, Oertel WH, Arnulf I, Ferini-Strambi L, Puligheddu M, Antelmi E, Cochen De Cock V, Arnaldi D, Mollenhauer B, Videnovic A, Sonka K, Jung KY, Kunz D, Dauvilliers Y, Provini F, Lewis SJ, Buskova J, Pavlova M, Heidbreder A, Montplaisir JY, Santamaria J, Barber TR, Stefani A, St Louis EK, Terzaghi M, Janzen A, Leu-Semenescu S, Plazzi G, Nobili F, Sixel-Döring F, Dusek P, Bes F, Cortelli P, Ehgoetz Martens K, Gagnon JF, Gaig C, Zucconi M, Trenkwalder C, Gan-Or Z, Lo C, Rolinski M, Mahlknecht P, Holzknecht E, Boeve AR, Teigen LN, Toscano G, Mayer G, Morbelli S, Dawson B, Pelletier A. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain. 2019;142(3):744-759.
- DOI: 10.1093/brain/awz030
- PMCID: PMC6391615
- Large multicenter study (n=1,280) confirming that most patients with idiopathic RBD eventually develop a neurodegenerative disorder, warranting neurological evaluation.
123. Sharpless BA. Exploding head syndrome. Sleep Medicine Reviews. 2014;18(6):489-493.
- DOI: 10.1016/j.smrv.2014.03.001
- PMID: 24703829
- Review establishing exploding head syndrome as a benign parasomnia with lifetime prevalence around 10%, higher in insomnia patients. Reassurance and education are typically sufficient treatment.
Sleep and Metabolism
124. Spiegel K, Tasali E, Penev P, Van Cauter E. Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Annals of Internal Medicine. 2004;141(11):846-850.
- DOI: 10.7326/0003-4819-141-11-200412070-00008
- PMID: 15583226
- Landmark study. Sleep restriction to 4 hours per night for 2 nights decreased leptin by 18%, increased ghrelin by 28%, and increased self-reported hunger by 24%, especially for calorie-dense carbohydrates.
125. Taheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Medicine. 2004;1(3):e62.
- DOI: 10.1371/journal.pmed.0010062
- PMCID: PMC535701
- Large population study (n=1,024) from the Wisconsin Sleep Cohort. Habitual short sleep (5 hours vs. 8 hours) associated with 15.5% lower leptin and 14.9% higher ghrelin, independent of BMI.
126. Cappuccio FP, Taggart FM, Kandala NB, Currie A, Peile E, Stranges S, Miller MA. Meta-analysis of short sleep duration and obesity in children and adults. Sleep. 2008;31(5):619-626.
- DOI: 10.1093/sleep/31.5.619
- PMCID: PMC2398753
- Meta-analysis of 45 studies (n=634,511). Short sleep duration associated with 55% increased odds of obesity in adults and 89% increased odds in children.
Treatment-Resistant Insomnia
127. Morin CM, Vallières A, Guay B, Ivers H, Savard J, Mérette C, Bastien C, Baillargeon L. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. JAMA. 2009;301(19):2005-2015.
- DOI: 10.1001/jama.2009.682
- PMID: 19454639
- Landmark trial establishing that approximately 10-15% of chronic insomnia patients do not achieve remission even with full-course CBT-I, defining the treatment-resistant population.
128. Morin CM. Treatment-resistant insomnia: Definition, prevalence, and management. Journal of Clinical Psychiatry. 2013;74(7):e14.
- PMID: 23945460
- Defines treatment-resistant insomnia as failure to respond to at least two evidence-based treatments (one behavioral, one pharmacologic) delivered at adequate dose and duration. Prevalence estimate: 10-15% of chronic insomnia population.
Sleep Trackers and Orthosomnia
129. Baron KG, Abbott S, Jao N, Manalo N, Mullen R. Orthosomnia: are some patients taking the quantified self too far? Journal of Clinical Sleep Medicine. 2017;13(2):351-354.
- DOI: 10.5664/jcsm.6472
- PMCID: PMC5263088
- Introduced the term "orthosomnia" and documented cases where sleep tracker data worsened insomnia by increasing sleep-related anxiety and perpetuating unhelpful behaviors.
130. de Zambotti M, Cellini N, Goldstone A, Colrain IM, Baker FC. Wearable sleep technology in clinical and research settings. Medicine & Science in Sports & Exercise. 2019;51(7):1538-1557.
- DOI: 10.1249/MSS.0000000000001947
- PMCID: PMC6579636
- Review confirming consumer sleep trackers have limited accuracy for sleep staging compared to polysomnography, particularly for distinguishing wake from light sleep.